vTv Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $-24 | $0 | $0 | $0 |
Gross Profit | -2 | -3 | -9 | |
EBITDA | -8,242 | -10,338 | -7,718 | -6,494 |
EBIT | -8,244 | -10,340 | -7,721 | -6,503 |
Net Income | -7,138 | -8,698 | -6,046 | -5,092 |
Net Change In Cash | -24 | 0 | 0 | 0 |
Free Cash Flow | -9,251 | -5,222 | -5,095 | -5,687 |
Cash | 88,932 | 98,504 | 25,922 | 31,059 |
Basic Shares | 8,423 | 8,055 | 6,587 | 6,582 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,017 | $9 | $2,018 |
Gross Profit | -16 | 1,017 | -90 | 2,018 |
EBITDA | -32,792 | -22,516 | -25,863 | -24,766 |
EBIT | -32,808 | -22,605 | -25,953 | -24,858 |
Net Income | -26,974 | -18,462 | -20,250 | -19,164 |
Net Change In Cash | 0 | 1,017 | 9 | 2,018 |
Cost of Revenue | -1,289 | |||
Free Cash Flow | -25,255 | -25,307 | -19,081 | -15,267 |
Cash | 88,932 | 36,746 | 9,446 | 12,126 |
Basic Shares | 8,423 | 5,771 | 2,084 | 1,919 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.58 |
2025-09-30 | -$1.08 |
2025-06-30 | -$0.92 |
2025-03-31 | -$0.77 |
